Integrated BioPharma, Inc. (OTCMKTS:INBP) Sees Significant Decrease in Short Interest

Integrated BioPharma, Inc. (OTCMKTS:INBPGet Rating) saw a large decrease in short interest in the month of May. As of May 31st, there was short interest totalling 800 shares, a decrease of 55.6% from the May 15th total of 1,800 shares. Based on an average daily volume of 7,000 shares, the short-interest ratio is presently 0.1 days.

Integrated BioPharma stock opened at $0.66 on Friday. The company has a market cap of $19.75 million, a PE ratio of 3.14 and a beta of 0.28. The company’s 50-day moving average is $0.76 and its two-hundred day moving average is $0.89. Integrated BioPharma has a 1 year low of $0.27 and a 1 year high of $1.19.

Integrated BioPharma Company Profile (Get Rating)

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States, Luxembourg, and Canada. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments.

See Also

Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.